Style | Citing Format |
---|---|
MLA | Sobhani H, et al.. "Rapamycin-Loaded, Capryol™ 90 and Oleic Acid Mediated Nanoemulsions: Formulation Development, Characterization and Toxicity Assessment." Iranian Journal of Pharmaceutical Research, vol. 17, no. 3, 2018, pp. 830-850. |
APA | Sobhani H, Tarighi P, Ostad SN, Shafaati A, Nafissivarcheh N, Aboofazeli R (2018). Rapamycin-Loaded, Capryol™ 90 and Oleic Acid Mediated Nanoemulsions: Formulation Development, Characterization and Toxicity Assessment. Iranian Journal of Pharmaceutical Research, 17(3), 830-850. |
Chicago | Sobhani H, Tarighi P, Ostad SN, Shafaati A, Nafissivarcheh N, Aboofazeli R. "Rapamycin-Loaded, Capryol™ 90 and Oleic Acid Mediated Nanoemulsions: Formulation Development, Characterization and Toxicity Assessment." Iranian Journal of Pharmaceutical Research 17, no. 3 (2018): 830-850. |
Harvard | Sobhani H et al. (2018) 'Rapamycin-Loaded, Capryol™ 90 and Oleic Acid Mediated Nanoemulsions: Formulation Development, Characterization and Toxicity Assessment', Iranian Journal of Pharmaceutical Research, 17(3), pp. 830-850. |
Vancouver | Sobhani H, Tarighi P, Ostad SN, Shafaati A, Nafissivarcheh N, Aboofazeli R. Rapamycin-Loaded, Capryol™ 90 and Oleic Acid Mediated Nanoemulsions: Formulation Development, Characterization and Toxicity Assessment. Iranian Journal of Pharmaceutical Research. 2018;17(3):830-850. |
BibTex | @article{ author = {Sobhani H and Tarighi P and Ostad SN and Shafaati A and Nafissivarcheh N and Aboofazeli R}, title = {Rapamycin-Loaded, Capryol™ 90 and Oleic Acid Mediated Nanoemulsions: Formulation Development, Characterization and Toxicity Assessment}, journal = {Iranian Journal of Pharmaceutical Research}, volume = {17}, number = {3}, pages = {830-850}, year = {2018} } |
RIS | TY - JOUR AU - Sobhani H AU - Tarighi P AU - Ostad SN AU - Shafaati A AU - Nafissivarcheh N AU - Aboofazeli R TI - Rapamycin-Loaded, Capryol™ 90 and Oleic Acid Mediated Nanoemulsions: Formulation Development, Characterization and Toxicity Assessment JO - Iranian Journal of Pharmaceutical Research VL - 17 IS - 3 SP - 830 EP - 850 PY - 2018 ER - |